Gitterman Wealth Management’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-845
| Closed | -$297K | – | 105 |
|
|
2023
Q2 | $297K | Sell |
845
-343
| -29% | -$121K | 0.14% | 43 |
|
|
2023
Q1 | $374K | Buy |
+1,188
| New | +$374K | 0.18% | 26 |
|
|
2022
Q4 | – | Sell |
-768
| Closed | -$221K | – | 93 |
|
|
2022
Q3 | $221K | Sell |
768
-105
| -12% | -$30.2K | 0.23% | 54 |
|
|
2022
Q2 | $249K | Sell |
873
-344
| -28% | -$98.1K | 0.23% | 48 |
|
|
2022
Q1 | $318K | Buy |
+1,217
| New | +$318K | 0.26% | 47 |
|